Hosted on MSN11mon
Japan’s PMDA approves Partner’s inhaled Leukine for aPAPIt assessed Leukine in 64 subjects with mild to moderate aPAP. Subjects were randomised in a 1:1 ratio to receive either Leukine 125μg or a placebo twice a day for seven days, followed by seven ...
Hosted on MSN1mon
Molgramostim shows promise in rare lung disease treatmentThe data, published in ERJ Open Research, indicates that molgramostim may improve lung function, reduce disease burden, and decrease the need for whole lung lavage (WLL), a current treatment for aPAP.
-- The Simple, No-cost Test Can Detect Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Autoantibodies in the Blood with Only a Finger Prick -- The DBS test demonstrates a high ...
(RTTNews) - Savara Inc. (SVRA), a biopharmaceutical company, Thursday announced that it has introduced the aPAP ClearPath Dried Blood Spot Test in the U.S. This new test builds on its prior serum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results